One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study-Reference-Cited by-同舟云学术

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study

Published:2017-06-08 Issue:3 Volume:46 Page:310-321
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Amiot A.¹^ORCID,Serrero M.²,Peyrin-Biroulet L.³,Filippi J.⁴,Pariente B.⁵,Roblin X.⁶^ORCID,Buisson A.⁷^ORCID,Stefanescu C.⁸,Trang-Poisson C.⁹,Altwegg R.¹⁰,Marteau P.¹¹,Vaysse T.¹²,Bourrier A.¹¹,Nancey S.¹³,Laharie D.¹⁴,Allez M.¹¹,Savoye G.¹⁵,Moreau J.¹⁶,Vuitton L.¹⁷,Viennot S.¹⁸,Aubourg A.¹⁹,Pelletier A.-L.¹¹,Bouguen G.²⁰,Abitbol V.¹¹,Gagniere C.¹,Bouhnik Y.⁸,

Affiliation:

1. Creteil France

2. Marseille France

3. Nancy France

4. Nice France

5. Lille France

6. Saint-Etienne France

7. Clermont-Ferrand France

8. Clichy France

9. Nantes France

10. Montpellier France

11. Paris France

12. Kremlin Bicêtre France

13. Lyon France

14. Bordeaux France

15. Rouen France

16. Toulouse France

17. Besançon France

18. Caen France

19. Tours France

20. Rennes France

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14167/fullpdf

Reference20 articles.

1. Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease;Fiorino;Expert Rev Clin Immunol,2010

2. Review article: anti-adhesion therapies for inflammatory bowel disease;Lobaton;Aliment Pharmacol Ther,2014

3. Vedolizumab as induction and maintenance therapy for ulcerative colitis;Feagan;N Engl J Med,2013

4. Vedolizumab as induction and maintenance therapy for Crohn's disease;Sandborn;N Engl J Med,2013

5. Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed;Sands;Gastroenterology,2014

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proactive therapeutic drug monitoring and vedolizumab dose optimization in children with inflammatory bowel disease;Journal of Pediatric Gastroenterology and Nutrition;2024-01-25

2. Terapia biológica en el adulto mayor con enfermedad inflamatoria intestinal: revisión narrativa;Universitas Médica;2024-01-24

3. A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis;Biomedicines;2023-12-06

4. Biological treatment interruption in inflammatory bowel disease: Motivation and predictive factors;Gastroenterología y Hepatología (English Edition);2023-11

5. ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse;Clinical Gastroenterology and Hepatology;2023-11